Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

ApaTech Announce Management Appointments

ApaTech Limited (ApaTech) has appointed Jill Schiaparelli to the company as vice president - commercial strategy and business development of the company and Melanie Marshall as vice president - clinical operations of the company. Both Jill and Melanie will report to chief executive officer Simon Cartmell and will become members of the company’s senior management team. The company also appointed Todd Clearwater as vice president - national sales in the US.

In his role, Jill will be responsible for global commercial strategy and all US and OUS marketing activities including commercial input to new product development and portfolio expansion through acquisition and licensing. Prior to joining ApaTech Jill held a series of global strategy and marketing positions at Johnson and Johnson, including Ethicon/Ethicon Endo.

In his role, Melanie will be responsible for the conduct of pre and post approval clinical studies and the acquisition of clinical data in support of marketing and regulatory objectives. Immediately before joining ApaTech Melanie was responsible for clinical strategy and execution across several divisions of Boston Scientific, prior to which she gained extensive experience in the Spine division of Medtronic Inc.

Todd had a successful career at Kyphon, setting up and managing their national market expansion activities. Following his time at Kyphon, Todd served as Senior Vice President Sales at Interventional Spine Inc. Todd will be responsible for all US sales and sales related activities reporting to Steve Czick, president, ApaTech.

Commenting on these appointments Simon Cartmell, chief executive officer, said “Our continuing rapid growth is driven by the quality of people we have been able to hire and these appointments are further examples of our ability to attract the highest calibre candidates. I am confident Jill, Melanie and Todd will all make significant contributions to our mission to redefine the orthobiologics market place.”